While the relationship between epicardial coronary vasomotor reactivity and cardiovascular events is well established, this observation has yet to be evaluated within the left main coronary artery (LMCA) in humans in vivo. Our aims were to test the endothelium-dependent vasomotor properties of the LMCA, and to compare these responses to downstream epicardial segments.
Introduction
Atherosclerosis is a diffuse, systemic disease, driven by a host of endogenous and environmental risk factors. Yet its complications invariably result from a culmination of processes promoting accelerated disease progression, localized regions of disease instability, and subsequent thrombo-embolic complications. 1 Endothelial dysfunction is characterized by the reduced bioavailability of nitric oxide (NO) and a resultant impairment of a number of NO-mediated vasomotor, anti-thrombotic, and anti-atherosclerotic effects; 2 a key component of which includes plaque stabilization. 3 Segmental vasoconstriction may play a synergistic role in mediating acute plaque events and is implicated not only in the progression of disease, 4, 5 but possibly also plaque erosion and rupture. 6, 7 Although thoroughly investigated within the epicardial and coronary microvasculature in humans in vivo, 8 a direct evaluation of left main coronary artery (LMCA) endothelium-dependent vasomotor reactivity has not been previously reported in humans. A mechanistic understanding of these factors in this segment is of obvious importance, as the consequences of LMCA disease and occlusion can be sudden and catastrophic.
We recently reported a novel imaging approach of direct intracoronary (IC) stimulation during coronary intravascular ultrasonography (IVUS). 9 This enabled volumetric appraisals of lumen response and plaque burden in contiguous, non-overlapping whole epicardial coronary segments across large sections of the coronary tree in vivo, enabling the validation of intracoronary salbutamol (and thus selective coronary b 2 -adrenoreceptor stimulation) as an epicardial and coronary microvascular endothelium-dependent vasomotor stimulus. 8 We further elucidated that the degree of segmental epicardial vasomotor reactivity per unit of underlying plaque volume remained constant irrespective of the nature of clinical presentation [non-ST segment elevation myocardial infarction (NSTEMI) vs. stable, noncritical coronary disease]. 10 Given that this invasive protocol involved infusing IC salbutamol via the coronary guiding catheter placed within the ostium of the left (or right) coronary arteries, the direct stimulation and subsequent IVUS imaging of whole, matched LMCA segments was possible. We thus chose to assess the nature and extent of LMCA vasomotor reactivity in humans in vivo. We tested the hypothesis that conduit vasomotor reactivity across the LMCA and downstream epicardial segments may be heterogenous, with a variation in the structure -function relationship of segments across the coronary tree.
Methods

Study subjects
Forty-seven patients (aged ≥18 years) referred for a clinically indicated coronary angiogram were initially recruited for a previous study that assessed the relationship between coronary atheroma volume and segmental epicardial endothelium-dependent vasomotor reactivity in subjects with stable, minimal angiographic disease vs. those with NSTEMI. 10 The present post hoc analysis pooled data from 30 of the original 47 patients, representing only the individuals undergoing invasive assessment of their left coronary system (with available analysable, matched LMCA images), thus enabling a specific interrogation of their LMCA segment. There were four additional patients in whom adequate sampling/matching of LMCA frames was deemed technically inadequate by the Core Lab, and the present analysis does not include those individuals. The chosen vessel for IC provocation and imaging in this group of patients was invariably the longest vessel (left anterior descending or left circumflex) containing numerous side-branches (for ease of anatomical matching) and minimal tortuosity, for more stable IVUS imaging. Of these 30 patients who underwent left-sided coronary imaging, 13 patients presented with stable (troponin T-negative), minimally detectable (,30% visual angiographic stenosis) coronary disease throughout the entire epicardial tree, whereas 17 presented with chest discomfort in concert with a significant elevation in troponin T with/without ECG changes. In these NSTEMI patients, the invasive research protocol was performed in a non-critically diseased (,30% angiographic stenosis), non-culprit ('study') vessel, prior to percutaneous coronary intervention within the culprit vessel, adopting the same angiographic inclusion/exclusion criteria for selection of the study vessel as the stable, near-normal cohort. Following informed consent, vasoactive medications were held for at least 24 h prior to the invasive study. All procedures were performed in the morning prior to an overnight fast. Exclusion criteria included significant valvular heart disease, left ventricular dysfunction (ejection fraction ≤40%), prior percutaneous or surgical revascularization, acute coronary syndrome within the preceding 4 weeks (in the near-normal cohort), known coronary spasm, severe obstructive lung disease, creatinine clearance ≤60 mL/min, b-blocker use in the preceding 24 h, or the use of short-or long-acting b 2 agonists within the previous 12 h. This study was approved by the Royal Adelaide Hospital Human Research Ethics Committee.
Cardiac catheterization and intravascular imaging protocols
Coronary angiography was performed via a standard 6-Fr technique. Intravenous heparin (70 IU/kg) was administered. A 0.014-inch coronary guide wire was placed into the study vessel within its mid-segment away from major side-branches. This wire was also used to deliver a 2.5-Fr 40 MHz Atlantic Pro IVUS catheter (Boston Scientific, Natick, MA, USA) into the study artery. This was undertaken without pre-treatment with IC nitroglycerin. If percutaneous coronary intervention was to be performed to a culprit lesion, this was done immediately following the invasive research protocol. All IC infusions were administered through an infusion pump at 2 mL/min via the coronary guiding catheter for a period of 5 min. Following 3 min of IC infusion (of either vehicle solution or salbutamol), the IVUS catheter was then moved from within the guiding catheter into the distal conduit vessel and images were acquired during automated catheter withdrawal at 0.5 mm/s, during which time the infusions continued. Towards the end of the IVUS pullback, care was taken to minimally disengage the guiding catheter in order to image the ostial LMCA-aortic junction. Our previous validation study showed that repeated, consecutive, IC vehicle infusions over 5 min during IC instrumentation with IVUS has no significant impact on changes in lumen measurements over time. 9 The IVUS images were recorded on a DVD for off-line analysis.
Coronary infusion and endothelial function testing protocols
The infusion protocols performed for validating IC salbutamol as an endothelium-dependent coronary vasomotor stimulus were previously described in detail. 9, 11 The rationale for choosing IC salbutamol over IC acetyl choline (ACh) in patients undergoing repeated IVUS imaging without pre-treatment with IC nitroglycerin related to a concern regarding the possibility of inducing clinically significant coronary spasm with an ACh-based protocol, particularly involving the LMCA segment. We chose salbutamol as our endothelium-dependent vasodilator as a series of in vivo human observations had proven coronary b 2--adrenoreceptor stimulation resulted in NO-mediated peripheral and coronary arterial vasomotor responses. 9,11 -14 This analysis comprised of the differences in lumen dimensions obtained following baseline vehicle infusion (IC 5% dextrose) and following a 5-min infusion of IC salbutamol at the 0.30 mg/min dose.
Left main coronary endothelial function
Data acquisition and analysis
Analysis of IVUS data was performed by the Atherosclerosis Imaging Core Laboratory, Cleveland Clinic, according to prior experience and published guidelines. 15, 16 Technicians were blinded to clinical details and imaging sequence. Proximal and distal fiduciary markers (anatomical side-branches) were chosen to define the overall region of vessel to be analysed, as well as for segment matching. Cross-sectional images were selected every 30 frames (0.5 mm apart). Frames that precluded complete lumen or vessel wall planimetry were excluded from analysis, as were segments that involved branch points. Each IVUS pullback of the epicardial vessel was divided into 5 mm epicardial segments comprising of 11 frames taken at 10 evenly spaced cross-sectional (0.5 mm) intervals ( Figure 1 ). Due to variations in the length of the LMCA segment across the cohort, the entire LMCA segment was analysed, providing that a minimum of 2 mm (five consecutive frames) of matched LMCA segment could be analysed. The non-LMCA (or epicardial) segments were divided according to their proximal, mid, or distal location ( Figure 2 ). For the left anterior descending artery (LAD), segments between the LAD ostium until the first major septal branch or first diagonal branch (whichever came first) were considered 'proximal.'
Segments between the first septal (or first diagonal) branch until the second diagonal branch were considered 'mid.' All segments distal to the second diagonal branch were considered 'distal.' For the left circumflex artery (LCx), segments between the LCx ostium until the first obtuse marginal branch were considered 'proximal.' Segments positioned between the first and second obtuse marginal were considered 'mid.' All segments distal to the second obtuse marginal branch were considered 'distal' (Figure 2 ). Given the proposed segmental heterogeneity of coronary vasomotor reactivity, 17 -20 each segment was thus analysed separately as an individual entity, with appropriately utilized statistical methods. Matching frames of anatomical side-branches from the baseline and post-salbutamol stimulation IVUS runs were co-registered to ensure accurate segment matching between runs. Leading edges of the lumen and external elastic membrane (EEM) were manually planimetered. Segmental plaque burden was calculated as the average plaque area (area between EEM and lumen -plaque interface), as well as PAV: ).
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Segmental lumen dimensions were expressed as average lumen areas (LAs), taken as the average of all LAs of each frame analysed per segment. Segmental eccentricity indices (EIs) were determined by calculating the average of all EIs of each analysable frame within a coronary segment (EI ¼ ratio of maximal-to-minimal plaque thickness). All measurements were performed by two analysts blinded to the specific infusion sequence. Intra-and inter-observer variability analysis was performed following planimetry of lumen and plaque areas from 20 randomly selected IVUS frames by two-independent observers and by one observer at two time points separated by 1 week.
Observer variability
For coronary lumen measurements, the intra-observer coefficient of variation was 1.1%, and inter-observer coefficient of variation was 2.6%. For plaque measurements, the intra-observer coefficient of variation was 1.8%, and the inter-observer coefficient of variation was 3.8%.
Statistical analysis
Data are expressed as mean + standard deviation (SD) or median and 25th and 75th percentiles, as appropriate, for continuous data. Categorical data are presented as a percent of non-missing data. Spearman correlation coefficients were used to describe the correlation between plaque burden and endothelial function. Ultrasonic characteristics are compared across segment type using Student's t-test for normally distributed data and Wilcoxon rank-sum for non-normally distributed data. Absolute change and percent change in LA are summarized as least-squared means (LSmeans) from a mixed model analysis with adjustment for the baseline LA measurement and the presence of acute coronary syndrome (vs. stable coronary syndrome) at presentation. All analyses were Figure 2 : Segmentation of the LMCA and epicardial coronary tree. For the LAD, segments between the LAD ostium until the first major septal branch (S1) or first diagonal branch (D1) (whichever came first) were considered 'proximal.' Segments between S1 (or D1) until the second diagonal branch (D2) were considered 'mid.' All segments distal to the D2 branch were considered 'distal.' For the LCx, segments between the LCx ostium until the first obtuse marginal branch (OM1) were considered 'proximal.' Segments positioned between OM1 and second obtuse marginal (OM2) were considered 'mid.' All segments distal OM2 were considered 'distal'. 
Results
Clinical, angiographic, and haemodynamic data Table 1 describes clinical, biochemical, and angiographic characteristics of the patient group. Mean age was 58 + 12 years and 70% of the population were male, 63% smokers, 17% had diabetes, and 50% hypertensive. Mean fasting low-density lipoprotein cholesterol (LDL-C) was 109 + 35 mg/dL, high-density lipoprotein cholesterol was 39 + 13 mg/dL, and the median high-sensitivity C-reactive protein level was 3 mg/L. The median LMCA length was 6.5 (2.5, 8.5) mm. The LAD was interrogated 70% of the time. Intracoronary salbutamol (0.30 mg/min for 5 min) resulted in no significant change in heart rate or blood pressure from baseline. 9, 10 None of the 30 patients reported side effects during the invasive protocol.
Ultrasonic characteristics and vasomotor reactivity according to the segment type Table 2 and Figure 3 segment (n ¼ 30) had significantly larger LA (P , 0.001 for any differences across segments), EEM area (P , 0.001 for any differences across segments), and average plaque area (P , 0.001 for any differences across segments). However, compared with the epicardial segments, the LMCA had significantly smaller PAV (P ¼ 0.02 for any differences across segments) and EIs (P , 0.001 for any differences across segments). Following IC salbutamol provocation, the LMCA and proximal epicardial segments underwent modest changes in LA (absolute change in LA: P ¼ 0.87; % change in LA: P ¼ 0.16) from baseline. However, significant endotheliumdependent vasodilatation from baseline was noted in the mid (absolute change in LA: P ¼ 0.085; % change in LA: P ¼ 0.017) and distal (absolute change in LA: P ¼ 0.001; % change in LA: P , 0.001) epicardial segments. Left main coronary endothelial function During specific interrogation of the LAD, the LMCA segment had a significantly larger EEM, LA, and average plaque area than the proximal, mid, and distal LAD segments. The LMCA segment also contained the least eccentric plaque compared with the proximal, mid, and distal LAD segments (P , 0.001 for any statistical differences across all groups). Following IC salbutamol provocation, the LMCA and proximal LAD segments underwent modest, non-significant changes in LA (absolute change in LA: P ¼ 0.18; % change in LA: P ¼ 0.65) from baseline. However, significant endotheliumdependent vasodilatation from baseline was noted in the mid (absolute change in LA: P ¼ 0.023; % change in LA: P ¼ 0.002) and distal (absolute change in LA: P , 0.001; % change in LA: P , 0.001) LAD segments.
Compared with data from the LAD, a similar pattern of plaque, vessel, and baseline lumen characteristics was found during LCx interrogation. The LMCA segment had a significantly larger EEM and LA than the proximal, mid, and distal LCx segments (P , 0.001 for any statistical differences across all groups for all described parameters). Again (and owing to the larger overall size of the LMCA segment), while the average plaque area of the LMCA segment was greater compared with epicardial LCx segments (P , 0.001 for differences across groups), PAV of the LMCA was the smallest in comparison with that of the epicardial LCx segments (P ¼ 0.068 for any statistical differences across all groups). Akin to observations from the LAD, the LMCA segment also contained the least eccentric plaque compared with the proximal, mid, and distal LCx segments (P , 0.001 for any statistical differences across all groups). Following IC salbutamol provocation, LMCA segments demonstrated significant endothelium-dependent vasodilatation (absolute change in LA: P ¼ 0.013; % change in LA: P ¼ 0.024) from baseline. On the other hand, all the epicardial LCx segments (proximal, mid, and distal) demonstrated modest, non-significant changes in LA, with a tendency towards vasoconstriction.
Correlations between plaque burden and endothelial function according to the segment Table 3 describes Spearman correlation coefficients for relationships between PAV and changes in LAs (absolute and % change). No significant correlations were noted between baseline PAV and vasomotor reactivity in the LMCA segment. A trend towards an inverse correlation between PAV and vasomotor reactivity was evident proximal and mid epicardial coronary segments. Significant inverse correlations were noted between PAV and changes in LA in the distal epicardial segments. Figure 4 illustrates the per-patient heterogeneity of segmental coronary vasomotor reactivity across all LMCA and epicardial segments. This pictorially demonstrates the marked variation in vasomotor response between adjacent epicardial segments, as well as opposing responses of the LMCA and epicardial segments, in virtually all 30 patients.
Heterogeneity of segmental coronary endothelial function
Given the known physiological interactions between baseline vessel size, flow, and endothelial function, 21 which is thought to be mediated by wall shear stress (WSS), we assessed the relationship between baseline segmental LA and stimulated lumen responses (% change in baseline LA). There was a significant relationship between baseline LA and % change in LA (r ¼ 20.17, P ¼ 0.0005; Figure 5 ).
Discussion
The present analysis is the first to demonstrate the endotheliumdependent vasomotor reactivity of the LMCA segment in humans in vivo, with direct comparisons of the structure and function of downstream LAD and LCx epicardial segments. These results demonstrate that although the LMCA segment differs in size and structure compared with the downstream epicardial vasculature, NO-dependent vasomotor reactivity was measurable following direct provocation with the selective b 2 -adrenoreceptor agonist, salbutamol. With the higher image resolution obtained with IVUS, accurate quantification of segmental lumen responses in relation to underlying plaque volume and topography was obtained, providing a unique insight into the vast heterogeneity of the structure-function relationship of the conduit (LMCA and epicardial) coronary system. Segmental heterogeneity of epicardial (but not LMCA) vasomotor responses has been previously described using coronary angiography. 17 -19 These studies utilized sub-selective IC ACh injections into a proximal portion of an epicardial vessel, by-passing the LMCA. By measuring lumen responses of all measurable contiguous segments distal to the infusion catheter, Penny et al. 18 further emphasized opposing segmental vasomotor responses within the same coronary segment following differing doses of IC ACh. Kato et al.
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observed IC ACh and bradykinin to elicit opposing vasomotor responses within the same segment. Seminal studies of coronary endothelial function found significant associations between the presence of endothelial dysfunction and incident cardiovascular events. 23 -25 Similarly, many small-scale mechanistic studies demonstrated associations between various risk factors, biomarkers, and plaque phenotype with the presence of epicardial endothelial dysfunction. 8, 20 Yet common to most of these studies was the assessment of only a focalized (2-3 mm length) segment of conduit vessel, and thus a limited representation of the coronary tree. Evaluating responses along the entire length of imaged epicardial conduit, in addition to the LMCA segment, overcomes selection bias, and has important implications for future evaluation of coronary vasomotor reactivity. In the present analysis, the demonstration of a greater tendency of more distally located conduit segments to display endotheliumdependent vasodilatation could be a result of an increasing proximal-to-distal gradient of NO bioavailability along the epicardial coronary vasculature. Alternatively, coronary arterioles and myocardial resistance vessels are thought to contain up to a five-fold greater density of endothelial b-adrenoreceptors compared with upstream epicardial segments.
14 A likely explanation for the blunted vasomotor response in the LMCA and proximal epicardial segments relates to the significant microvascular vasodilation and subsequent augmentation of coronary blood flow following IC salbutamol. This is likely to have resulted in an upstream flow-mediated effect. 9, 11 However, the demonstration of an inverse relationship between baseline LA and segmental vasomotor reactivity in the present analysis is consistent with the known physiological associations between vessel size, flow, and the degree of NO-mediated response. 21 Regional WSS is believed to be the stimulus for flowmediated NO-dependent responses, which is invariably greater in smaller sized segments. This may explain the tendency for the larger calibre LMCA and proximal epicardial segments to Left main coronary endothelial function demonstrate less vasomotor reactivity. Indeed, diminished responses to IC ACh have also previously been described in the proximal compared with mid-distal epicardial coronary vasculature. 27 Furthermore, with the topography and enhanced image resolution of IVUS, we observed a predilection for plaque to accumulate in greater amounts within the LMCA and proximal epicardial segments, compared with distal epicardial segments. Collectively, these observations may help explain why culprit lesions for myocardial infarction more commonly cluster within the proximal epicardial coronary tree. 28 -31 The presence of segmental variation in endothelium-dependent vasomotor reactivity may relate to the variable nature of disease progression along the coronary tree. Opposing serial responses of the LMCA arterial wall to a range of established anti-atherosclerotic therapies was recently described, compared with the corresponding epicardial segment. 32 Associations between the baseline burden of LMCA plaque, its rate of progression, and constrictive remodelling with incident clinical events were also elucidated. These observations were noted in a sample of 340 patients enrolled in serial IVUS trials. Similar associations between plaque burden and disease progression have been described in the non-LMCA coronary tree, albeit in populations requiring a much larger sample size to demonstrate this association. 16, 33 This suggests that pathophysiological characteristics intrinsic to the LMCA may be a more sensitive marker of the overall behaviour of the conduit coronary vasculature, possibly better reflecting coronary risk. The coronary vasculature forms the substrate for a majority of mortal and non-mortal cardiovascular events, and there is difficulty in extrapolating surrogate measures of disease burden and vessel function from the peripheral circulation to the coronary tree. The larger dimensions of the LMCA segment, compared with its distal tributaries, enable non-invasive LMCA imaging as a possible means of risk stratifying at-risk patients for incident coronary events. This approach would also be applicable to a far broader patient population than invasive coronary imaging technologies. As a proof-of-concept, cardiac magnetic resonance imaging was successful in non-invasively demonstrating epicardial coronary vasomotor reactivity following isometric handgrip. 34 Further studies are required to determine the reproducibility of these findings, as well as standardizing the methodology for non-invasively assessing coronary structure and function, prior to a large-scale, prospective appraisal of its prognostic capacity. Given that larger calibre vessels typically demonstrate less vasomotor reactivity, from a practical viewpoint therefore, the present analysis suggests that a specific functional assessment of the LMCA segment may prove difficult to quantify non-invasively, or with an imaging modality with lesser resolution than IVUS. As such, the LMCA segment perhaps remains more attractive for structural plaque imaging, whereas the epicardial tree is able to be assessed both structurally and functionally along most of its length. The heterogeneity of segmental epicardial vascular responses, coupled with the prognostic utility of both plaque burden and vasomotor reactivity, emphasizes the need to develop imaging strategies that improve our ability to better identify individuals at greatest risk of their sentinel cardiovascular event.
A number of caveats of the present analysis warrant further consideration. Precise mechanisms underlying the apparent progressive gradient of greater vasomotor reactivity, occurring distally along the conduit vessel, were not ascertained from this study. Part of this reasoning, however, may relate to inherent differences in structural components of the arterial wall along the coronary tree. Given its proximity to the aorta, the ostial portion of the LMCA is likely subject to vastly different WSS conditions than the remainder of the coronary system. The proximal LMCA is also known to harbour greater amounts of smooth muscle cells, and lacks surrounding adventitia. The density of smooth muscle cells is also thought to lessen distally along the coronary tree. 35 The behaviour of the LCx also seems to differ from observations from within the LAD. This may simply relate to a smaller number of LCx vessels/segments examined in our analysis, or because of the differing amounts of salbutamol that could have reached each epicardial vessel based on blood flow division/diversion at the LAD-LCx bifurcation following infusion into the LMCA. However, the blunted NO-dependent vasomotor capacity of the entire LCx system is consistent with the prior demonstration of plaque ruptures found more diffusely along the entire length of LCx vessel, compared with the greater predilection for these plaque ruptures to accumulate within more proximal portions of the LAD. 28 More recently, an autopsy study revealed the LCx to harbour more thin-capped fibroatheromas compared with the LAD and RCA. 36 Collectively, these observations suggest that structural and functional features of plaque vulnerability may be harboured over proportionally greater lengths of the LCx artery compared with the LAD, although this requires further investigation. Plaque composition was not assessed in this analysis, which might have provided added mechanistic insights into the variable nature of plaque vulnerability along the coronary tree, yet is itself not without certain limitations. 37, 38 Bifurcating segments were purposely not evaluated, due to difficulties in assessing lumen dimensions across these regions. Direct vasodilator responses to intracoronary nitroglycerin injection were not evaluated. This would have allowed us to test if smooth muscle cell dysfunction, rather than impairment in NO-dependent function, contributed to blunted vessel wall reactivity in a number of segments. Salbutamol, however, has minimal direct smooth muscle cell dilating properties, as shown in a prior validation study. 9 In conclusion, the present analysis achieved its objectives of emphasizing, for the first time in man, the endothelium-dependent vasomotor reactivity of the LMCA segment and its relationship to its tributary branches. Heterogenous and opposing vascular responses between adjacent coronary segments were observed, along with an apparent increasing gradient of NO-dependent segmental responses along distally along the epicardial coronary tree. These novel mechanistic observations provide additional support for the proximal clustering of culprit plaques. Such findings also have broader implications for improving imaging methodologies required to advance the field of coronary imaging into clinical practice, with the ultimate aim of better stratifying coronary risk.
